Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia
NCT01550640
Cardiovascular Diseases, Cesarean Delivery
Prague, Czechia
View Trial DetailsNCT Number: NCT06030063
The SOAP registry is a prospective, multicenter, electronic registry. The goal is to investigate the indications, mode of airway management, predisposing factors, and obstetric and anesthetic outcomes of pregnant patients who receive general anesthesia for cesarean delivery.
Interested in participating?
Request Info15 year–55 year
Female
Observational
Royal Columbian Hospital & University of British Columbia, New Westminster, Canada
This is a central repository with data from 25-40 participating SOAP institutions/hospitals.
The primary and secondary aims of this study are as follows:
Data will be collected from each participating SOAP institution. Institutional data will include information on the characteristics of the institution such as maternal level of care, numbers of lives birth, staffing models, etc. This data will be collected prior to subjects being enrolled into the registry and again at the registry closure to look at intuitional changes over time.
Inclusion into the registry is based on the following criteria:
The general anesthesia registry will collect data on subject demographics in a deidentified manner, including characteristics of the birth and delivery, gestational age, maternal morbidities, and anesthetic management.
The granular detail requested in the registry database will help to better understand the nuances of how and why decisions are made about proceeding with general anesthesia in these cases, and once done, how to implement this clinical course. As not all of these data points are routinely recorded in the medical record, optimal data capture requires the treating anesthesiologist to complete the registry entry as soon as possible after conclusion of patient care.
Data will be collected for approximately 5 years and maintained indefinitely. Data is entered into a Yale REDCap registry and will not contain subject identifiers. An estimated 5000 subjects will be enrolled into the data repository. This is based on a published report of 45 institutions' data investigating a subtopic of this question (15 years yielding 15,000 general anesthetics).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-Pregnant women aged 15-55 who have had a general anesthetic for Cesarean delivery
Time frame: Up to 5 years
The rates of general anesthesia for cesarean delivery among the institutions in the cohort will be assessed. Descriptive analyses of etiologies of and management of general anesthetics for cesarean delivery will also be performed.
Time frame: Up to 5 years
The association between facility type- non-academic affiliated private vs. academic affiliated private vs. military vs. academic (reference)- with a difference in rates of general anesthesia for cesarean delivery will be assessed.
Time frame: Up to 5 years
The association between SOAP center of excellence designation- yes (reference) vs. no- with a difference in rates of general anesthesia for cesarean delivery will be assessed.
Time frame: Up to 5 years
The association between maternal level of care- I vs. II vs. III vs. IV (reference)- with a difference in rates of general anesthesia for cesarean delivery will be assessed.
Time frame: Up to 5 years
The association between increased numbers of annual live births (continuous variable) and a difference in rates of general anesthesia for cesarean delivery will be assessed.
Time frame: Up to 5 years
The association between increased rates of labor and delivery floor coverage by obstetric anesthesiologists (continuous variable) and a difference in rates of general anesthesia for cesarean delivery will be assessed.
Time frame: Up to 5 years
The association between the presence of institutional policies for labor epidural management- yes (reference) vs. no- and a difference in rates of general anesthesia for cesarean delivery will be assessed.
Time frame: Up to 5 years
Among the cohort of general anesthetics for cesarean delivery, the incidence of difficult intubation will be determined.
Time frame: Up to 5 years
The association between increased Mallampati score- I or II (reference) vs. III vs. IV- and a difference in risk of difficult intubation will be assessed.
Time frame: Up to 5 years
The association between neck mobility- full (reference) vs. limited vs. poor and a difference in risk of difficult intubation will be assessed.
Time frame: Up to 5 years
The association between neck circumference- thin or average (reference) vs. thick and a difference in risk of difficult intubation will be assessed.
Time frame: Up to 5 years
The association between neck length- long or average (reference) vs. short and a difference in risk of difficult intubation will be assessed.
Time frame: Up to 5 years
The association between thyromental distance- >6.5cm (reference) vs. 3.5-6.5cm vs. <3.5cm and a difference in risk of difficult intubation will be assessed.
Contact information is provided by the study sponsor or research team.
Yale University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01550640
Cardiovascular Diseases, Cesarean Delivery
Prague, Czechia
View Trial DetailsNCT07082530
Cesarean Delivery
Hangzhou, Zhejiang, China
View Trial DetailsNCT07362992
Blood Loss, Surgical, Cesarean Delivery
Holon, Central District, Israel
View Trial DetailsNCT07326644
Body Weight, Body Weight Changes
Elâzığ, Elaziğ, Turkey (Türkiye)
View Trial Details